Thomas F. Pajak

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

Jay S. Cooper, Thomas F. Pajak, Arlene A. Forastiere et al. · New England Journal of Medicine · 2004 · 3.3K citations

Medicine, Oncology, Radiation Oncology +6

Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer

Arlene A. Forastiere, Helmuth Goepfert, Moshe Maor et al. · New England Journal of Medicine · 2003 · 3.2K citations · Full text

Medicine, Otolaryngology, Surgery +11

Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

Jacques Bernier, Jay S. Cooper, Thomas F. Pajak et al. · Head & Neck · 2005 · 1.8K citations

Medicine, Otolaryngology, Radiation Oncology +10

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003

Karen K. Fu, Thomas F. Pajak, Andy Trotti et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 1.4K citations

Medicine, Oncology, Radiation Oncology +17

Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal Cancer

David P. Kelsen, Robert J. Ginsberg, Thomas F. Pajak et al. · New England Journal of Medicine · 1998 · 1.4K citations

Medicine, Oncology, Surgery +7